ANI Pharmaceuticals (ANIP) PT Raised to $60 at Raymond James
Tweet
Share
E-mailGet Alerts ANIP Hot Sheet
Price: $76.54 --0%
Rating Summary:
10 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 10 | New: 16
Rating Summary:
10 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 10 | New: 16
Join SI Premium – FREE
Raymond James analyst Elliot Wilbur raised the price target on ANI Pharmaceuticals (NASDAQ: ANIP) to $60.00 (from $40.00) while maintaining a Outperform rating.
You May Also Be Interested In
- ANI Pharmaceuticals (ANIP) PT Lowered to $119 at Guggenheim
- CrowdStrike (CRWD) PT Raised to $235 at TD Cowen
- Palo Alto Networks (PANW) PT Raised to $400 at TD Cowen
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
